Our results demonstrated that TNFAIP3 upregulation strongly inhibited CRC proliferation, invasion, and migration, therefore signaling that it can be used as a promising therapeutic target for CRC treatment. This evidence concerns the gene TNFAIP3 and colorectal carcinoma.